Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3007919	s-fascab	— (—)	77	81	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7.94

23.58

1.1

1.0

—

Other diseases of blood and blood-forming organs, wide

24.04

17.28

1.0

—

ILD medications: immunosuppressive drugs

7.37

15.50

1.1

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

5.94

15.12

1.1

1.0

—

ILD medications

5.58

14.51

1.1

1.0

—

Dermatitis

6.27

13.19

1.0

1.1

—

First line medication for Crohn's disease

5.25

12.92

1.1

1.0

—

L04AX Other immunosuppressants

6.18

12.44

1.1

1.0

—

Oral corticosteroids

5.11

12.36

1.1

1.0

—

Inflammatory bowel disease treatment related agents

4.73

11.87

1.1

1.0

—

Asthma (mode)

7.85

11.83

1.0

—

Asthma

7.69

11.53

1.0

—

Second line medication for Crohn's disease

5.68

11.45

1.1

1.0

—

Asthma (only as main-diagnosis)

7.72

11.10

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

7.62

10.94

1.1

1.0

—

Asthma, excluding more controls

7.30

10.59

1.0

—

Dermatitis and eczema

4.32

10.24

1.0

1.1

—

Intestinal infectious diseases

4.36

10.04

1.1

1.0

—

Other and unspecified dermatitis

7.41

8.90

1.1

1.0

—

Asthma, hospital admissions , main diagnosis only

4.31

8.12

1.0

—

Asthma (diagnoses ohter than nonallergic)

3.97

7.90

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

4.29

7.75

1.1

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.83

7.60

1.1

1.0

—

Autoimmune diseases related-to ILD

3.92

7.50

1.0

—

Intestinal infectious diseases

3.59

7.16

1.0

—

6.90

6.93

1.1

1.0

—

Other respiratory diseases principally affecting the interstitium

13.77

6.88

1.3

1.0

—

Asthma-related infections

5.69

6.76

1.1

—

Asthma, hospital admission 2, infections

5.69

6.76

1.1

—

Atopic dermatitis

4.37

6.17

1.1

1.0

—

General symptoms and signs

3.44

5.76

1.0

1.1

—

Asthma, unspecified (mode)

7.53

5.73

1.1

1.0

—

Asthma, unspecified (mode), excluding more controls

7.48

5.70

1.1

1.0

—

Suggestive for eosinophilic asthma

16.03

5.41

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.04

5.23

1.0

1.1

—

COPD/asthma/ILD related infections

3.51

5.20

1.0

—

COPD/asthma related infections

3.51

5.20

1.0

—

ILD, hospital admissions

13.35

5.07

1.4

1.0

—

Interstitial lung disease

13.35

5.07

1.4

1.0

—

Interstitial lung disease endpoints

13.35

5.07

1.4

1.0

—

Other interstitial pulmonary diseases

13.35

5.07

1.4

1.0

—

Autoimmune diseases excluding thyroid diseases

2.97

5.02

1.0

1.1

—

Fever of other and unknown origin

5.19

4.98

1.0

1.1

—

Asthma, including avohilmo

2.87

4.81

1.0

1.1

—

Infections, IBD-co-morbidities

10.72

4.80

1.0

—

Explicit Sepsis

5.90

4.79

1.0

—

Systemic connective tissue disorders

5.72

4.74

1.0

—

Diaphragmatic hernia

7.14

4.64

1.2

1.0

—

Chronic lower respiratory diseases

2.83

4.64

1.0

1.1

—

Other septicaemia

6.22

4.62

1.0

—

Other and unspecified anaemias

6.17

4.58

1.1

1.0

—

Other anaemias

6.15

4.57

1.1

1.0

—

Bacterial infection, other or unspecified

4.67

4.57

1.0

1.1

—

Enlarged lymph nodes

14.01

4.57

1.0

—

Acute upper respiratory infections

3.01

4.51

1.0

—

Septicaemia

5.35

4.48

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.43

4.41

1.0

—

3.43

4.41

1.0

—

Any gastric operation

3.96

4.34

1.0

1.1

—

GASTRO-related operations

3.96

4.34

1.0

1.1

—

Aplastic and other anaemias

5.70

4.33

1.1

1.0

—

Bacterial infection, other or unspecified

4.38

4.32

1.0

1.1

—

2.84

4.09

1.0

—

ILD medications: azathioprine

12.01

3.76

1.2

1.0

—

Azathioprine

12.01

3.76

1.2

1.0

—

Anaemias

6.53

3.70

1.0

—

Other diseases of the digestive system

5.63

3.65

1.0

—

GI-bleeding

5.63

3.65

1.0

—

Examination and observation for other reasons

4.18

3.64

1.1

—

Other diseases of intestines

2.65

3.61

1.0

1.1

—

Influenza and pneumonia

2.57

3.52

1.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

3.69

3.51

1.0

1.1

—

Allergic asthma (mode)

9.79

3.45

1.0

—

Allergic asthma (mode), excluding more controls

9.79

3.45

1.0

—

Osteopathies and chondropathies

3.85

3.43

1.1

1.0

—

Malaise and fatigue

4.73

3.41

1.1

—

Other bacterial intestinal infections

7.00

3.36

1.0

—

Bacterial intestinal infections, IBD co-morbidities

7.00

3.36

1.0

—

Other bacterial intestinal infections

5.72

3.34

1.0

—

Papulosquamous disorders

4.35

3.30

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.06

3.22

1.2

1.0

—

Urticaria and erythema

4.17

3.19

1.0

—

Irritable bowel syndrome

5.34

3.19

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

4.01

3.18

1.0

—

Other pulmonary diagnosis

4.01

3.18

1.0

—

COPD differential diagnosis

4.01

3.18

1.0

—

ILD differential diagnosis

4.01

3.18

1.0

—

Other and unspecified tonsillitis

4.73

3.14

1.0

—

Atopic dermatitis, strict definition with reimbursement

4.57

3.13

1.0

—

FESS (DNB20)

7.51

3.05

1.2

1.0

—

Ethmoidectomy

7.51

3.05

1.2

1.0

—

Special screening examination for infectious and parasitic diseases

6.44

3.03

1.0

—

L04AA Selective immunosuppressants

5.84

3.02

1.4

1.0

—

Aortic aneurysm

7.36

3.01

1.2

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

2.65

3.01

1.0

—

Other anxiety disorders

3.53

2.91

1.0

—

Noninfective enteritis and colitis

3.43

2.89

1.0

—

Codes for special purposes

3.33

2.80

1.3

1.0

—

Provisional assignment of new diseases of uncertain etiology

3.33

2.80

1.3

1.0

—

Pain in throat and chest

2.73

2.79

1.1

1.0

—

Diseases of liver

4.45

2.79

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

2.36

2.78

1.1

—

Other bacterial diseases

2.48

2.76

1.0

1.1

—

Other infectious diseases

8.34

2.75

1.2

1.0

—

Atopic dermatitis, strict definition

3.83

2.71

1.0

—

Persons encountering health services for examination and investigation

3.34

2.70

1.0

1.1

—

Other diseases of liver

6.00

2.69

1.0

—

Nasal polyp

6.00

2.69

1.0

—

Pain in joint

3.19

2.69

1.1

—

Diseases of the digestive system

3.43

2.67

1.0

—

All pneumoniae

2.31

2.66

1.1

—

Insomnia

2.48

2.64

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

3.40

2.62

1.1

—

Sleep disorders

2.46

2.60

1.0

1.1

—

L04AD Calcineurin inhibitors

7.15

2.55

1.6

1.0

—

7.15

2.55

1.0

—

Transplanted organ and tissue status

7.15

2.55

1.6

1.0

—

Acute pancreatitis

5.46

2.54

1.0

—

Acute pancreatitis (for exclusion)

5.46

2.54

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

5.46

2.54

1.0

—

Other systemic involvement of connective tissue

5.46

2.54

1.0

—

Dyspnoea

2.41

2.52

1.2

1.0

—

Asthma-related pneumonia

4.37

2.47

1.0

—

Asthma-related pneumonia or sepsis

4.37

2.47

1.0

—

Asthma, hospital admissions 3, pneumonia

4.37

2.47

1.0

—

Abnormal findings on diagnostic imaging of lung

3.45

2.45

1.2

1.0

—

Certain infectious and parasitic diseases

2.70

2.43

1.0

—

Anxiety (asthma-related co-morbidities)

2.73

2.41

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.63

2.41

1.0

1.2

—

Nonorganic sleeping disorders

5.00

2.40

1.0

—

Reimbursement for rheumatic diseases

2.88

2.39

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.23

2.37

1.1

—

Lichen planus, including avohilmo

6.25

2.37

1.0

—

Paralytic ileus and intestinal obstruction

6.25

2.37

1.0

—

Urticaria

3.64

2.36

1.0

—

Chronic sinusitis

3.21

2.30

1.2

1.1

—

Nonorganic sleeping disorders, excluding more controls

4.62

2.27

1.0

—

Diagnoses used for exclusion with ILD

4.62

2.27

1.3

1.0

—

Chronic gastritis

4.62

2.27

1.2

1.0

—

Other bacterial diseases

2.25

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.27

2.22

1.0

1.1

—

Diseases of the respiratory system

3.47

2.22

1.0

—

Pain, not elsewhere classified

5.56

2.21

1.2

1.0

—

Acute pharyngitis

5.51

2.20

1.0

—

Diseases of the skin and subcutaneous tissue

2.43

2.18

1.0

1.1

—

All anxiety disorders

2.56

2.17

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

3.32

2.16

1.0

—

Bleeding

2.37

2.13

1.0

1.1

—

Liquid cancers, helper endpoint

3.32

2.13

1.0

—

Open wound of head

2.59

2.09

1.1

1.0

—

Haemorrhage from respiratory passages

4.16

2.07

1.0

—

5-aminosalicylic acid

5.00

2.07

1.0

—

Other headache syndromes

2.90

2.06

1.0

—

Conjunctivitis (acute, non atopic)

3.49

2.04

1.0

—

Psoriasis

4.00

2.04

1.0

—

Lower back pain or/and sciatica

2.13

2.03

1.1

1.0

—

Disorders of gallbladder, biliary tract and pancreas

2.19

2.02

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

2.47

2.01

1.2

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.40

2.00

1.2

1.0

—

Other functional intestinal disorders

3.09

2.00

1.1

1.0

—

Tramadol

2.32

1.99

1.1

1.0

—

Bacterial pneumonia, not elsewhere classified

3.42

1.98

1.0

—

Other disorders of skin and subcutaneous tissue

2.51

1.97

1.2

1.1

—

Vasomotor and allergic rhinitis

3.02

1.97

1.1

1.0

—

Acute sinusitis

2.78

1.95

1.2

1.0

—

Diseases of arteries, arterioles and capillaries

2.54

1.94

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

4.55

1.94

1.0

—

Asthma/COPD (KELA code 203)

2.19

1.93

1.1

—

Bacterial pneumoniae

3.25

1.88

1.0

—

Pneumonia, organism unspecified

2.15

1.86

1.1

—

Depression medications

3.52

1.84

1.0

—

Implicit bacterial Sepsis

3.18

1.84

1.0

—

Degeneration of macula and posterior pole

3.67

1.84

1.0

—

Ulcerative colitis

3.53

1.83

1.0

—

Other arthritis (FG)

3.04

1.79

1.1

1.0

—

Inflammatory bowel disease

3.04

1.79

1.0

—

Covid-19 confirmed case

3.04

1.79

1.3

1.0

—

Abnormalities of breathing

2.29

1.78

1.2

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

4.33

1.77

1.2

1.0

—

Depression

2.05

1.76

1.1

—

Obesity related asthma

3.33

1.74

1.0

—

Polyarthropathies

2.23

1.74

1.1

—

Autoimmune diseases

1.99

1.73

1.0

1.1

—

Visual disturbances

2.67

1.72

1.1

1.0

—

Implicit bacterial Sepsis

3.32

1.71

1.0

—

Allergic rhinitis

2.88

1.70

1.1

1.0

—

Any reimbursement code in KELA

2.64

1.69

1.0

—

Ovarian cyst

3.11

1.69

1.0

1.1

—

Benzodiazepine use

2.00

1.69

1.0

1.1

—

Disorders of other endocrine glands

2.62

1.68

1.0

—

Triptan medication for migraine, min. 3 purchases

2.54

1.67

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

2.28

1.66

1.0

—

IBD patients in KELA-register

3.16

1.66

1.0

—

Other specified/unspecified arthritis

3.16

1.66

1.2

1.0

—

Bacterial Sepsis

2.85

1.65

1.0

—

Persons encountering health services in other circumstances

2.79

1.64

1.0

—

Viral and other specified intestinal infections

3.08

1.62

1.0

—

Mood disorders, excluding more controls

1.99

1.61

1.1

—

Adverse effects, not elsewhere classified

3.57

1.61

1.0

—

Bacterial pneumonia (organism specified)

2.76

1.60

1.0

—

Inflammatory bowel disease, strict (require KELA)

3.00

1.58

1.0

—

3.53

1.58

1.2

1.0

—

Acute appendicitis, no complications

2.31

1.58

1.1

1.0

—

Recurrent or chronic depression

2.56

1.57

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.34

1.57

1.0

—

Pollen allergy

2.96

1.56

1.0

—

Myalgia

3.33

1.52

1.0

—

Colonic or urogenital fistula

3.33

1.52

1.0

—

Intestinal stricture

3.33

1.52

1.0

—

Gastroduodenal ulcer

3.32

1.52

1.2

1.0

—

Disorders of adult personality and behaviour

2.86

1.50

1.2

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.86

1.50

1.2

1.0

—

Other systemic involvement of connective tissue (FG)

3.29

1.50

1.0

—

Cholelithiasis

2.12

1.47

1.1

—

Viral and other specified intestinal infections

2.76

1.44

1.0

—

Mood [affective] disorders

1.88

1.44

1.1

—

Fall on and from stairs and steps

3.13

1.44

1.2

1.0

—

Mycoses

3.13

1.44

1.2

1.0

—

Mood disorders

1.88

1.43

1.1

—

Other and unspecified iron deficiency

2.73

1.43

1.0

—

Cough

2.70

1.41

1.2

1.0

—

Chronic kidney disease

3.06

1.41

1.2

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.53

1.40

1.0

—

Parasetamol

2.06

1.39

1.0

—

Appendectomy

2.17

1.38

1.0

1.1

—

Cardiovascular diseases

2.19

1.37

1.0

—

Rheumatoid arthritis, including avohilmo

2.94

1.36

1.0

—

Neurotic, stress-related and somatoform disorders

1.92

1.36

1.1

—

Exclusions for E4_PCOS_BROAD

2.94

1.35

1.0

—

STROKE

0.00

1.35

0.0

1.0

—

Anxiety disorders

1.91

1.34

1.1

—

Diseases of the musculoskeletal system and connective tissue

2.26

1.34

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

1.84

1.33

1.3

1.0

—

Other antidepressants

1.86

1.33

1.0

1.1

—

Nausea and vomiting

2.88

1.33

1.0

—

Sciatica+with lumbago

2.37

1.29

1.0

1.1

—

Visual disturbances and blindness

2.35

1.29

1.1

1.0

—

Leiomyoma of uterus

2.39

1.28

1.0

1.1

—

Subjective visual disturbances

2.78

1.28

1.0

—

Other noninfective gastroenteritis and colitis

2.78

1.28

1.0

—

Caries of enamel

1.87

1.28

1.1

—

Disorders of skin appendages

2.28

1.26

1.0

—

Pure hypercholesterolaemia

2.05

1.25

1.1

—

Caries of dentine

2.70

1.24

1.0

—

Other heart diseases

2.27

1.24

1.0

—

Cholelithiasis, broad definition with cholecystitis

1.97

1.24

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.63

1.21

1.0

—

In situ neoplasms

2.63

1.21

1.2

1.0

—

Used for control exclusion in common control thyroid runs

1.80

1.21

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.25

1.21

1.0

1.1

—

Gastro-oesophageal reflux disease

2.05

1.20

1.0

—

Persons encountering health services in other circumstances, wide

1.75

1.20

1.0

—

Migraine

2.09

1.16

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.46

1.15

1.0

—

Specific personality disorders

2.50

1.15

1.2

1.0

—

Care involving use of rehabilitation procedures

2.00

1.14

1.1

—

Rheumatoid arthritis

2.49

1.13

1.0

1.1

—

Injuries to the ankle and foot

1.92

1.13

1.0

1.1

—

Other specific joint derangements/joint disorders

1.89

1.12

1.1

—

Abnormal serum enzyme levels

2.44

1.11

1.2

1.1

—

Dental caries

2.40

1.10

1.0

—

Nutritional anaemias

2.18

1.07

1.1

1.0

—

Dorsalgia

1.79

1.07

1.0

—

Diverticular disease of intestine

2.05

1.07

1.0

1.1

—

Other and unspecified effects of external causes

2.27

1.03

1.0

—

Other disorders of lacrimal gland

2.27

1.03

1.0

—

Other soft tissue disorders, not elsewhere classified

1.75

1.02

1.1

1.0

—

Injuries to the head

1.67

1.02

1.1

1.0

—

Other intervertebral disc disorders

1.89

1.02

1.1

—

Abdominal and pelvic pain

1.76

1.01

1.0

1.1

—

Anxiety disorders, excluding more controls

1.76

1.00

1.1

—

Implicit Sepsis

1.88

1.00

1.0

1.1

—

Transient ischemic attack

0.00

0.99

0.0

1.0

—

Certain infectious and parasitic diseases

2.06

0.99

1.0

—

Other abnormal products of conception

0.00

0.98

0.0

1.0

—

Other reaction to severe stress, and adjustment disorders

2.17

0.98

1.2

1.0

—

Appendicitis, broad definition

1.81

0.97

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1.94

0.96

1.0

1.1

—

Diseases of appendix

1.80

0.96

1.1

—

Low back pain

1.89

0.96

1.2

1.1

—

Excessive earwax

1.90

0.94

1.1

—

Disorders of lens

1.89

0.94

1.1

—

Ischaemic heart disease, wide definition

1.88

0.92

1.1

—

Persons encountering health services for specific procedures and health care

1.63

0.90

1.1

—

Disorders of lacrimal system

2.06

0.89

1.0

—

Chronic diseases of tonsils and adenoids

1.78

0.88

1.1

—

Iron deficiency anaemia

2.04

0.88

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.63

0.88

1.1

1.0

—

Lumbar disc prolapse

1.86

0.87

1.1

—

Hernia

1.71

0.86

1.2

1.0

—

Exposure to unspecified factor

1.62

0.86

1.1

1.0

—

Spondylopathies

1.81

0.83

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.94

0.83

1.0

1.1

—

Disorders of choroid and retina

1.78

0.82

1.2

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.81

0.0

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.80

0.81

1.0

—

1.72

0.81

1.0

1.1

—

Nerve, nerve root and plexus disorders

0.50

0.81

1.2

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.60

0.80

1.3

1.0

—

Other obstetric conditions, not elsewhere classified

0.00

0.80

0.0

1.0

—

Acute appendicitis

1.73

0.79

1.1

—

Headache

1.84

0.79

1.0

1.1

—

Keratitis

0.00

0.79

0.0

1.0

—

Genitourinary diseases

1.79

0.78

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.69

0.77

1.0

1.1

—

Benign neoplasm: Colon

1.79

0.77

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.73

0.77

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.63

0.76

1.0

1.1

—

Other diseases of upper respiratory tract

1.59

0.75

1.0

—

Other cataract

2.10

0.75

1.0

—

Other retinal disorders

1.88

0.74

1.0

1.1

—

Obesity, other/unspecified

2.08

0.74

1.0

—

All kidney diseases

1.59

0.74

1.1

—

Basal cell carcinoma

2.04

0.73

1.0

—

Renal failure

2.01

0.72

1.2

1.0

—

Other disorders of veins

1.99

0.72

1.0

—

Depression or dysthymia

1.72

0.72

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.65

0.72

1.0

1.1

—

Disorders of conjunctiva

1.63

0.72

1.0

—

Mental and behavioural disorders due to alcohol

1.77

0.71

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

1.59

0.71

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.74

0.70

1.0

1.1

—

Inguinal hernia

1.73

0.70

1.1

1.0

—

Other viral diseases

1.92

0.70

1.0

—

Unspecified mental disorder

1.85

0.68

1.2

1.0

—

Striking against or struck by other objects

1.85

0.68

1.2

1.0

—

Disorders of synovium and tendon

1.66

0.68

1.1

—

Renal tubulo-interstitial diseases

1.61

0.67

1.1

—

Basal cell carcinoma, including avohilmo

1.81

0.66

1.0

—

Triptan medication for migraine, single purchase ok

1.65

0.66

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.65

0.66

1.0

—

Alcohol use disorder, Swedish definition

1.60

0.65

1.0

1.1

—

Acute bronchitis

1.75

0.65

1.4

1.0

—

Noninflammatory disorders of female genital tract

1.79

0.64

1.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.67

0.64

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.66

0.64

1.0

—

Alcohol use disorder, ICD-based

1.72

0.64

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.72

0.63

1.0

—

Tonsillectomy and adenotomy

1.69

0.63

1.1

1.0

—

Implicit Sepsis

1.62

0.63

1.0

1.1

—

Malignant neoplasm of prostate

0.00

0.63

0.0

1.2

—

Single delivery by forceps and vacuum extractor

0.00

0.62

0.0

1.0

—

Outcome of delivery

0.00

0.62

0.0

1.0

—

Pregnancy examination and test

0.00

0.62

0.0

1.0

—

Sleep disorders (combined)

1.50

0.62

1.0

1.1

—

Supervision of high-risk pregnancy

0.00

0.61

0.0

1.0

—

Malignant neoplasm of prostate, including Hilmo

0.00

0.61

0.0

1.1

—

Mouth breathing

1.66

0.61

1.0

1.1

—

Procreative management

1.67

0.61

1.4

1.0

—

Long labour

0.00

0.61

0.0

1.0

—

Sequelae of cerebrovascular disease

0.00

0.61

0.0

1.0

—

Hyperkinetic disorders

0.00

0.60

0.0

1.0

—

Disturbance of activity and attention

0.00

0.60

0.0

1.0

—

1.57

0.60

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.60

0.0

1.0

—

Obesity

1.54

0.59

1.0

1.1

—

Malignant neoplasm of skin

1.79

0.59

1.0

1.1

—

Irregular menses

1.75

0.58

1.0

—

Bronchitis

1.49

0.58

1.0

—

Obesity and other hyperalimentation

1.51

0.58

1.0

1.1

—

External causes of morbidity and mortality

1.61

0.58

1.0

1.1

—

Heart failure,strict

1.69

0.57

1.2

1.1

—

Mycoses

1.52

0.56

1.1

1.0

—

Percutaneous Coronary Intervention

1.53

0.55

1.4

1.0

—

Spondylosis

1.63

0.55

1.2

1.1

—

All-cause Heart Failure

1.63

0.55

1.2

1.1

—

Coronary revascularization (ANGIO or CABG)

1.53

0.55

1.4

1.0

—

Heart failure, strict

1.63

0.55

1.2

1.1

—

Symptoms and signs involving the urinary system

1.52

0.55

1.1

1.0

—

Obesity due to excess calories

1.58

0.54

1.0

—

Other dorsopathies, not elsewhere classified

1.49

0.53

1.0

—

Major coronary heart disease event excluding revascularizations

1.54

0.52

1.2

1.0

—

Major coronary heart disease event

1.43

0.52

1.3

1.0

—

Inflammatory diseases of female pelvic organs

1.52

0.52

1.2

1.0

—

Complications of surgical and medical care, not elsewhere classified

1.47

0.52

1.0

1.1

—

Opioids

1.48

0.52

1.0

—

Conjunctivitis

1.42

0.52

1.0

—

Other heart diseases, wide

1.47

0.51

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.46

0.51

1.0

1.1

—

All chronic kidney diseases

1.49

0.51

1.2

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

0.61

0.50

1.0

1.1

—

Gastrointestinal diseases

1.59

0.50

1.0

—

Exposure to other specified factors

1.50

0.50

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.55

0.48

1.1

1.0

—

Finngen Rheumatological endpoints

1.45

0.48

1.0

1.1

—

Caries of dentine, including avohilmo

0.59

0.48

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

1.43

0.46

1.0

—

Use of hypnotics and sedatives

1.41

0.46

1.0

1.1

—

Other disorders of urethra and urinary system

1.40

0.45

1.1

1.0

—

Selective serotonin reuptake inhibitors

1.42

0.44

1.0

1.1

—

Arthropathies

1.40

0.44

1.0

1.1

—

Type 2 diabetes, wide definition

1.46

0.43

1.1

—

Hypertensive diseases (excluding secondary)

1.61

0.43

1.0

—

Myocardial infarction

1.60

0.43

1.2

1.0

—

Complications of medical and surgical care

1.44

0.42

1.0

1.1

—

Other viral diseases

1.60

0.42

1.0

—

Erysipelas

1.58

0.42

1.0

1.1

—

Other nutritional deficiencies

1.42

0.42

1.0

1.1

—

Conduction disorders

0.00

0.41

0.0

1.0

—

Disorders of tooth development and eruption

0.00

0.41

0.0

1.0

—

Prolonged pregnancy

0.00

0.41

0.0

1.0

—

Fracture of femur

0.00

0.41

0.0

1.0

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.41

0.0

1.0

—

Perineal laceration during delivery

0.00

0.41

0.0

1.0

—

Primary open-angle glaucoma

0.00

0.41

0.0

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.51

0.41

1.2

1.0

—

severe traumatic brain injury, does not include concussion

0.00

0.41

0.0

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.41

0.0

1.0

—

Cervicobrachial syndrome

0.00

0.41

0.0

1.0

—

Tinnitus

0.00

0.41

0.0

1.0

—

Impingement syndrome of shoulder

0.00

0.41

0.0

1.1

—

Sulfonylureas

0.00

0.41

0.0

1.0

—

Persons with potential health hazards related to communicable diseases

1.50

0.41

1.0

—

Chronic apical periodontitis

0.65

0.41

1.0

—

Disorders of psychological development

0.00

0.40

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.40

0.0

1.0

—

Pedal cyclist injured in transport accident

0.00

0.40

0.0

1.0

—

Gestational [pregnancy-induced] hypertension

0.00

0.40

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

0.40

0.0

1.1

—

Fracture of rib(s), sternum and thoracic spine

0.00

0.40

0.0

1.0

—

Premature rupture of membranes

0.00

0.40

0.0

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

1.45

0.40

1.0

1.1

—

Emergency coronary revascularization (for ACS)

1.40

0.39

1.4

1.0

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.42

0.39

1.0

1.1

—

Cardiodefibrillation

0.00

0.39

0.0

1.0

—

Complications of procedures, not elsewhere classified

1.38

0.38

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

1.37

0.38

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.38

0.38

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

0.64

0.37

1.0

1.1

—

Artificial joint operation, meniscal resection

0.65

0.36

1.0

1.1

—

Erysipelas

1.43

0.36

1.0

1.1

—

Acute tubulo-interstitial nephritis

1.40

0.35

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.38

0.34

1.0

1.1

—

Sleep apnoea, including avohilmo

0.68

0.34

1.0

1.1

—

Other disorders of ear

0.67

0.33

1.0

1.1

—

Senile cataract

1.31

0.33

1.2

1.1

—

Coronary atherosclerosis

1.31

0.33

1.2

1.0

—

Injuries to the shoulder and upper arm

1.37

0.33

1.0

1.1

—

Psychiatric diseases

1.34

0.32

1.0

1.1

—

Episodal and paroxysmal disorders

1.30

0.32

1.0

1.1

—

Heart failure, not strict

1.36

0.31

1.1

—

Dental operations

1.33

0.31

1.0

—

Injuries to the wrist and hand

0.71

0.31

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.36

0.31

1.1

1.0

—

Infections of the skin and subcutaneous tissue

1.36

0.31

1.1

1.0

—

Falls/tendency to fall

0.74

0.30

1.0

—

Mental and behavioural disorders due to psychoactive substance use

1.30

0.30

1.0

1.1

—

Persons encountering health services in circumstances related to reproduction

1.27

0.30

1.3

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.24

0.29

1.1

—

Ischemic heart diseases

1.33

0.29

1.1

1.0

—

Dizziness and giddiness

1.23

0.29

1.0

1.1

—

Diseases of the ear and mastoid process

0.77

0.29

1.0

1.1

—

Hypertension, essential

1.29

0.28

1.0

1.1

—

Constipation

1.33

0.28

1.2

1.0

—

Cystitis

1.25

0.28

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.31

0.27

1.0

1.1

—

Any mental disorder

1.28

0.27

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

0.66

0.27

1.0

1.1

—

Pain in limb

1.22

0.27

1.3

1.0

—

Malignant neoplasm

0.67

0.27

1.0

1.1

—

Gonarthrosis,primary

0.68

0.27

1.2

1.1

—

Codeine

1.32

0.26

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.67

0.26

1.0

1.1

—

Hypothyroidism, other/unspecified

0.66

0.26

1.0

1.1

—

Other external causes of accidental injury

1.22

0.26

1.0

1.1

—

Accidents

1.22

0.26

1.0

1.1

—

Metabolic disorders

1.22

0.25

1.1

1.0

—

Diseases of the eye and adnexa

1.32

0.25

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.31

0.25

1.0

1.1

—

Any event in cancer register

0.74

0.25

1.0

1.1

—

Biguanides

0.73

0.25

1.0

1.1

—

Chronic periodontitis, including avohilmo

0.71

0.24

1.0

1.1

—

Periodontitis

0.70

0.24

1.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.40

0.24

1.2

1.0

—

Soft tissue disorders

1.26

0.23

1.0

—

Other acute lower respiratory infections

1.32

0.23

1.4

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.28

0.23

1.0

—

Alzheimer disease, excluding more controls

0.00

0.22

0.0

1.0

—

Other diseases of urinary system

1.26

0.22

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

0.21

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

1.0

—

Assault by bodily force

0.00

0.21

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

1.0

—

Pilonidal cyst

0.00

0.21

0.0

1.0

—

Eating disorder

0.00

0.21

0.0

1.0

—

Contact with machinery

0.00

0.21

0.0

1.0

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.21

0.0

1.0

—

Type 1 diabetes, definitions combined

0.00

0.21

0.0

1.0

—

Eating disorders

0.00

0.21

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

0.21

0.0

1.0

—

Lesion of ulnar nerve

0.00

0.21

0.0

1.0

—

Other condition

0.00

0.21

0.0

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

0.00

0.21

0.0

1.0

—

Spondylolisthesis/Spondylolysis

0.00

0.21

0.0

1.0

—

Other diseases of the respiratory system

0.00

0.21

0.0

1.0

—

Other respiratory disorders and diseases

0.00

0.21

0.0

1.0

—

DVT of lower extremities

0.00

0.21

0.0

1.0

—

Acute appendicitis, with complications

0.00

0.21

0.0

1.0

—

Nontraumatic intracranial haemmorrhage

0.00

0.21

0.0

1.0

—

Acute renal failure

0.00

0.21

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

0.21

0.0

1.0

—

N06DA Anticholinesterases

0.00

0.21

0.0

1.0

—

Use of anticholinesterases

0.00

0.21

0.0

1.0

—

Hypertensive Heart Disease

0.00

0.21

0.0

1.0

—

Deep bite

0.00

0.21

0.0

1.0

—

Insulin, fast-acting (human)

0.00

0.21

0.0

1.0

—

Early onset COPD

0.00

0.21

0.0

1.0

—

Thyrotoxicosis

0.00

0.21

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

0.21

0.0

1.0

—

Paroxysmal tachycardia

0.00

0.21

0.0

1.0

—

Corneal ulcer

0.00

0.21

0.0

1.0

—

Voice disturbances

0.00

0.21

0.0

1.0

—

Fracture of lumbar spine and pelvis

0.00

0.21

0.0

1.0

—

Primary open-angle glaucoma, strict

0.00

0.21

0.0

1.0

—

Personal history of other diseases and conditions

0.00

0.21

0.0

1.0

—

Fall on same level

0.78

0.20

1.1

1.0

—

Speech and linguistic disorders

0.00

0.20

0.0

1.0

—

Hyperkinetic disorders, excluding more controls

0.00

0.20

0.0

1.0

—

Peritonsillar abscess

0.00

0.20

0.0

1.0

—

Sulfasalazine

0.00

0.20

0.0

1.0

—

Excessive attrition of teeth

1.25

0.20

1.0

1.1

—

Substance abuse, excluding more controls

1.22

0.20

1.0

1.1

—

Cholecystectomy

1.20

0.20

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

1.20

0.18

1.0

—

Hypertensive diseases

1.13

0.17

1.0

1.1

—

Hypertension

1.13

0.17

1.0

1.1

—

Dental caries, including avohilmo

0.77

0.16

1.0

1.1

—

Sleep apnoea

0.76

0.16

1.0

1.1

—

Benign neoplasms

1.15

0.16

1.0

1.1

—

Dental pulpitis, including avohilmo

0.78

0.15

1.1

—

Neurological diseases

1.18

0.12

1.0

1.1

—

Dorsopathies

1.18

0.11

1.0

—

Intracranial injury

1.15

0.10

1.2

1.0

—

Fracture of lower leg, including ankle

1.15

0.10

1.0

—

Rotator cuff syndrome

1.12

0.10

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.14

0.09

1.0

—

Diseases of male genital organs

1.12

0.09

1.0

—

Substance abuse

1.13

0.09

1.0

1.1

—

Shoulder lesions

1.04

0.08

1.0

1.1

—

Intracranial trauma

0.82

0.08

1.2

1.0

—

Conductive and sensorineural hearing loss

0.77

0.08

1.0

1.1

—

Hard cardiovascular diseases

1.07

0.08

1.1

1.0

—

Solid cancers, helper endpoint

0.80

0.08

1.0

1.1

—

Other (not insulin) diabetes medications

0.85

0.07

1.0

1.1

—

Type 2 diabetes

1.05

0.07

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

1.03

0.07

1.1

—

Injuries to the knee and lower leg

1.09

0.04

1.1

1.0

—

Codeine or tramadol medication

1.07

0.02

1.0

1.1

—

Gingivitis and periodontal diseases

1.03

0.00

1.0

1.1

—

Nonspecific lymphadenitis

0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

0.0

1.0

—

Dermatophytosis

1.00

0.00

1.0

—

Mental retardation, wide definition

0.00

0.0

1.0

—

Parkinson's disease, strict definition

0.00

0.0

1.0

—

Thyrotoxicosis, other and/or unspecified

0.00

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

0.0

1.0

—

Other diseases of hard tissues of teeth

0.96

0.00

1.0

—

Cholecystitis

0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.0

1.0

—

Chalazion

0.00

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

1.0

—

Presbycusis

0.00

0.0

1.0

—

Sensorineural hearing loss

0.87

0.00

1.0

1.1

—

Polycystic ovarian syndrome

0.00

0.0

1.0

—

Early onset COPD, excluding more controls

0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

0.89

0.00

1.0

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.0

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

0.0

1.0

—

Bell's palsy

0.00

0.0

1.0

—

Diabetes medication

0.97

-0.00

1.1

—

Obsessive-compulsive disorder

0.00

-0.00

0.0

1.0

—

Mental retardation, excluding more controls

0.00

-0.00

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Injuries to the elbow and forearm

0.99

-0.00

1.0

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.0

—

Other metabolic disorders

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

-0.00

0.0

1.0

—

Diabetes, varying definitions

0.98

-0.00

1.1

—

Lung diseases due to external agents

0.00

-0.00

0.0

1.0

—

Brachial plexus disorders

0.00

-0.00

0.0

1.0

—

Purpura and other haemorrhagic conditions

0.00

-0.00

0.0

1.0

—

Social phobias

0.00

-0.00

0.0

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Other congenital malformations

0.00

-0.00

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

1.0

—

Other disorders starting during childhood or adolescence

0.00

-0.00

0.0

1.0

—

Maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

1.0

—

Mental retardation

0.00

-0.00

0.0

1.0

—

Open bite

0.00

-0.00

0.0

1.0

—

Pain associated with micturition

0.00

-0.00

0.0

1.0

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.0

—

Graves disease, strict definition

0.00

-0.00

0.0

1.0

—

Chronic viral hepatitis

0.00

-0.00

0.0

1.0

—

Other blood glucose lowering drugs, excl. Insulins

0.00

-0.00

0.0

1.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Nonischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Wide developmental disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

-0.00

0.0

1.0

—

Other joint disorders

0.96

-0.00

1.0

1.1

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.0

—

Intermittent heterotropia

0.00

-0.00

0.0

1.0

—

Trochanteric bursitis

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.0

—

Puerperal sepsis

0.00

-0.00

0.0

1.0

—

Disease of hard tissues of teeth, NOS

0.97

-0.00

1.0

—

Nail disorders

0.00

-0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

-0.00

0.0

1.0

—

Astigmatism

0.00

-0.00

0.0

1.0

—

Intracerebral haemorrhage

0.00

-0.00

0.0

1.0

—

Use of donepezil

0.00

-0.00

0.0

1.0

—

Contact with other sharp object(s)

0.00

-0.00

0.0

1.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Retained placenta and membranes, without haemorrhage

0.00

-0.00

0.0

1.0

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Cervicocranial syndrome

0.00

-0.00

0.0

1.0

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

1.0

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Retinal detachment with retinal break

0.00

-0.00

0.0

1.0

—

Concussion

0.97

-0.00

1.2

1.0

—

Parkinson's disease

0.00

-0.00

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

-0.00

0.0

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Inflammatory diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.0

—

Cardiac arrhythmias

0.96

-0.00

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

0.97

-0.00

1.0

1.1

—

Foreign body or object entering through skin

0.00

-0.00

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

-0.00

0.0

1.0

—

Fall on and from ladder

0.00

-0.00

0.0

1.0

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

1.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.0

—

Achilles tendinitis

0.00

-0.00

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

-0.00

0.0

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

-0.00

0.0

1.0

—

Statin medication

0.85

-0.00

1.0

—

Secondary hypertension

0.00

-0.00

0.0

1.0

—

Bronchitis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Other endocrine disorders

0.00

-0.00

0.0

1.0

—

Type 2 diabetes, definitions combined

1.00

-0.00

1.0

1.1

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

Other keratitis

0.00

-0.00

0.0

1.0

—

Other eating disorders

0.00

-0.00

0.0

1.0

—

Demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.0

—

Varicose veins of other sites

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

-0.00

0.0

1.0

—

Hypertrophy of breast

0.00

-0.00

0.0

1.0

—

Other disorders of bladder

0.00

-0.00

0.0

1.0

—

Other disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at hip and thigh level

0.00

-0.00

0.0

1.0

—

Mandibular retrognathia

0.00

-0.00

0.0

1.0

—

Open wound of ankle and foot

0.00

-0.00

0.0

1.0

—

Other Crohn's disease

0.00

-0.00

0.0

1.0

—

Polyhydramnios

0.00

-0.00

0.0

1.0

—

Focal brain injury

0.00

-0.00

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

-0.00

0.0

1.0

—

Failed induction of labour

0.00

-0.00

0.0

1.0

—

Seborrhoeic dermatitis

0.00

-0.00

0.0

1.0

—

Impacted maxillary molar

0.00

-0.00

0.0

1.0

—

Other specified and unspecified personality disorders

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

-0.00

0.0

1.0

—

Hypertrophy of breast in women and men

0.00

-0.00

0.0

1.0

—

Crohn's disease NAS

0.00

-0.00

0.0

1.0

—

Scoliosis

0.00

-0.00

0.0

1.0

—

Adenomyosis (Endometriosis of uterus)

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

-0.00

0.0

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.96

-0.00

1.1

—

Familial hypercholesterolemia

0.00

-0.00

0.0

1.0

—

Viral hepatitis

0.00

-0.00

0.0

1.0

—

Infectious mononucleosis

0.00

-0.00

0.0

1.0

—

KRA_PSY_EATING, excluding more controls

0.00

-0.00

0.0

1.0

—

Distal bite

0.00

-0.00

0.0

1.0

—

Schizoaffective disorder

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.0

—

Neoplasms

0.98

-0.00

1.0

1.1

—

Specific development disorders of scholastic skills

0.00

-0.00

0.0

1.0

—

Other viral hepatitis

0.00

-0.00

0.0

1.0

—

Melanocytic naevi of trunk

0.00

-0.00

0.0

1.0

—

Diabetes mellitus

0.97

-0.00

1.1

—

Endocrine, nutritional and metabolic diseases

0.89

-0.00

1.0

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

-0.00

0.0

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.00

-0.00

1.0

1.1

—

Parkinson's disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Disorders of thyroid, IBD co-morbidities

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Fasciola sp Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS